Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines

Sustainable access to affordable medicines remains a public health issue globally, including for high-income countries. To foster the debate on avenues for the future, the fifth PPRI Conference held in Vienna on 25 and 26 April 2024 will offer a forum for the debate on innovating pharmaceutical poli...

Full description

Saved in:
Bibliographic Details
Main Authors: Sabine Vogler, Nina Zimmermann, Manuel Alexander Haasis, Verena Knoll, Jaime Espin, Aukje K. Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman, Veronika J. Wirtz, Zaheer-Ud-Din Babar
Format: Article
Language:English
Published: Taylor & Francis Group 2024-04-01
Series:Journal of Pharmaceutical Policy and Practice
Online Access:https://www.tandfonline.com/doi/10.1080/20523211.2024.2335492
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576255975751680
author Sabine Vogler
Nina Zimmermann
Manuel Alexander Haasis
Verena Knoll
Jaime Espin
Aukje K. Mantel-Teeuwisse
Dimitra Panteli
Fatima Suleman
Veronika J. Wirtz
Zaheer-Ud-Din Babar
author_facet Sabine Vogler
Nina Zimmermann
Manuel Alexander Haasis
Verena Knoll
Jaime Espin
Aukje K. Mantel-Teeuwisse
Dimitra Panteli
Fatima Suleman
Veronika J. Wirtz
Zaheer-Ud-Din Babar
author_sort Sabine Vogler
collection DOAJ
description Sustainable access to affordable medicines remains a public health issue globally, including for high-income countries. To foster the debate on avenues for the future, the fifth PPRI Conference held in Vienna on 25 and 26 April 2024 will offer a forum for the debate on innovating pharmaceutical policymaking to develop and implement futureproof policy options, which are able to address current and future challenges. The Conference invites a broad audience of stakeholders, including researchers, policymakers, payers, patients, industry and health professionals. The conference topics are organised in three strands: Strand 1 on ‘Local challenges, global learnings’ aims to contribute to lively discussions on the implementation of pharmaceutical policies across the globe. Best-practice examples will be presented, supplemented by case studies of less effective policies which can offer rich learnings. Strand 2 on ‘Strengthening the evidence base’ is the place for presentations and discussions on topics such as health technology assessments, managed entry agreements and real-world data. Strand 3 ‘Futureproofing pharmaceutical policies’ is particularly dedicated to explore innovation in policymaking to achieve sustainable access to affordable medicines.
format Article
id doaj-art-f20760e2b6724b549f6dd5825cbb6700
institution Kabale University
issn 2052-3211
language English
publishDate 2024-04-01
publisher Taylor & Francis Group
record_format Article
series Journal of Pharmaceutical Policy and Practice
spelling doaj-art-f20760e2b6724b549f6dd5825cbb67002025-01-31T08:35:30ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112024-04-0117sup110.1080/20523211.2024.2335492Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicinesSabine Vogler0Nina Zimmermann1Manuel Alexander Haasis2Verena Knoll3Jaime Espin4Aukje K. Mantel-Teeuwisse5Dimitra Panteli6Fatima Suleman7Veronika J. Wirtz8Zaheer-Ud-Din Babar9WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH, Vienna, AustriaWHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH, Vienna, AustriaWHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH, Vienna, AustriaWHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH, Vienna, AustriaAndalusian School of Public Health, Granada, SpainWHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht University, Utrecht, the NetherlandsEuropean Observatory on Health Systems and Policies, Brussels, BelgiumWHO Collaborating Centre for Pharmaceutical Policy and Evidence Based Practice, School of Health Sciences, University of KwaZulu-Natal, Durban, South AfricaWHO Collaborating Center in Pharmaceutical Policy, Department of Global Health, Boston University School of Public Health, Boston, USADepartment of Pharmacy, University of Huddersfield, UKSustainable access to affordable medicines remains a public health issue globally, including for high-income countries. To foster the debate on avenues for the future, the fifth PPRI Conference held in Vienna on 25 and 26 April 2024 will offer a forum for the debate on innovating pharmaceutical policymaking to develop and implement futureproof policy options, which are able to address current and future challenges. The Conference invites a broad audience of stakeholders, including researchers, policymakers, payers, patients, industry and health professionals. The conference topics are organised in three strands: Strand 1 on ‘Local challenges, global learnings’ aims to contribute to lively discussions on the implementation of pharmaceutical policies across the globe. Best-practice examples will be presented, supplemented by case studies of less effective policies which can offer rich learnings. Strand 2 on ‘Strengthening the evidence base’ is the place for presentations and discussions on topics such as health technology assessments, managed entry agreements and real-world data. Strand 3 ‘Futureproofing pharmaceutical policies’ is particularly dedicated to explore innovation in policymaking to achieve sustainable access to affordable medicines.https://www.tandfonline.com/doi/10.1080/20523211.2024.2335492
spellingShingle Sabine Vogler
Nina Zimmermann
Manuel Alexander Haasis
Verena Knoll
Jaime Espin
Aukje K. Mantel-Teeuwisse
Dimitra Panteli
Fatima Suleman
Veronika J. Wirtz
Zaheer-Ud-Din Babar
Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
Journal of Pharmaceutical Policy and Practice
title Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
title_full Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
title_fullStr Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
title_full_unstemmed Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
title_short Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
title_sort innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
url https://www.tandfonline.com/doi/10.1080/20523211.2024.2335492
work_keys_str_mv AT sabinevogler innovationsinpharmaceuticalpoliciesandlearningsforsustainableaccesstoaffordablemedicines
AT ninazimmermann innovationsinpharmaceuticalpoliciesandlearningsforsustainableaccesstoaffordablemedicines
AT manuelalexanderhaasis innovationsinpharmaceuticalpoliciesandlearningsforsustainableaccesstoaffordablemedicines
AT verenaknoll innovationsinpharmaceuticalpoliciesandlearningsforsustainableaccesstoaffordablemedicines
AT jaimeespin innovationsinpharmaceuticalpoliciesandlearningsforsustainableaccesstoaffordablemedicines
AT aukjekmantelteeuwisse innovationsinpharmaceuticalpoliciesandlearningsforsustainableaccesstoaffordablemedicines
AT dimitrapanteli innovationsinpharmaceuticalpoliciesandlearningsforsustainableaccesstoaffordablemedicines
AT fatimasuleman innovationsinpharmaceuticalpoliciesandlearningsforsustainableaccesstoaffordablemedicines
AT veronikajwirtz innovationsinpharmaceuticalpoliciesandlearningsforsustainableaccesstoaffordablemedicines
AT zaheeruddinbabar innovationsinpharmaceuticalpoliciesandlearningsforsustainableaccesstoaffordablemedicines